ICCC (immucell.com) נכסים נקיים של החברה

ImmuCell Corporation (ICCC) dominates the US biotechnology segment for calf protection, where patents shield the business from cheap chemical substitutes. Its monopolist status in the development of immune agents allows the company to independently dictate pricing power. The price action, where the indicator stands at 0.03, complements data regarding the eco-friendly production of biological preparations with minimal environmental impact and strict resource control.

Steady demand for First Defense biologicals in the livestock sector forms the material base of ImmuCell Corporation (ICCC). By analyzing the current book value of equity, an investor can see the difference between all assets and liabilities, which objectively reflects the real value of the business devoid of market speculation. The trend of this indicator allows for an assessment of the company's internal stability and the degree of investment protection against volatility.